|
Report Date : |
02.11.2012 |
IDENTIFICATION DETAILS
|
Name : |
TOSHIBA MEDICAL SYSTEMS CORPORATION |
|
|
Registered Office : |
1385 |
|
|
|
|
|
|
Country : |
|
|
|
|
|
|
|
Financials (as on) : |
31.03.2012 |
|
|
|
|
|
|
Date of Incorporation : |
September 1948 |
|
|
|
|
|
|
Com. Reg. No.: |
(Tochigi-Otawara) 013525 |
|
|
|
|
|
|
Legal Form : |
Limited Company |
|
|
|
|
|
|
Line of Business : |
Manufacturer of medical equipment |
|
|
|
|
|
|
No. of Employees : |
3,682 |
|
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Good |
|
Payment Behaviour : |
Regular |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – June 30th, 2012
|
Country Name |
Previous Rating (31.03.2011) |
Current Rating (30.06.2012) |
|
|
A1 |
A1 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
In the years following World
War II, government-industry cooperation, a strong work ethic, mastery of high technology,
and a comparatively small defense allocation (1% of GDP) helped
Source : CIA
TOSHIBA MEDICAL SYSTEMS CORPORATION
REGD NAME: Toshiba
Medical Systems KK
MAIN OFFICE: 1385
Shimoishigami Otawara City Tochigi-Pref 324-8555
Tel: 0287-26-5100
Fax: 0287-26-6050
URL: http//:www.toshiba-medical.co.jp
E-mail: info@toshiba-medical co.jp
Manufacturer of
medical equipment
At the caption
address
SATOSHI TSUNAKAWA,
PRES Nobuhiro Washio, mgn dir
Hiroshi Asahina,
mgn dir Kazuya Kobayashi, mgn dir
Keiji Tanaka, mgn dir Toshio Yamanoi, dir
Yen Amount: In million Yen, unless otherwise stated
FINANCES FAIR A/SALES Yen 254,959 M
PAYMENTS REGULAR CAPITAL Yen 20,700 M
TREND UP WORTH Yen 39,475 M
STARTED 1948 EMPLOYES 3,682
MFR OF MEDICAL
EQUIPMENT, OWNED BY TOSHIBA CORP.
FINANCIAL SITUATION CONSIDERED FAIR AND GOOD
FOR ORDINARY BUSINESS ENGAGEMENTS
The subject company was
established on the basis of a medical equipment mfg division separated from
Toshiba Corp (See REGISTRATION). This is a specialized mfr of medical
equipment & instruments (See OPERATION). Strong in magnetic resonance imaging systems
and tops in this field. Third ranked in
The sales volume for Mar/2012 fiscal
term amounted to Yen 254,959 million, a 3% up from Yen 248,184 million in the
previous term. The recurring profit was
posted at Yen 11,965 million and the net profit at Yen 7,394 million,
respectively, compared with Yen 11,175 million recurring profit and Yen 8,367
million net profit, respectively, a year ago.
.
For the current term ending Mar 2013 the
recurring profit is projected at Yen 12,000 million and the net profit at Yen
7,500 million, respectively, on a 4% rise in turnover, to Yen 265,000
million.
The financial situation is
considered FAIR and good for ORDINARY business engagements.
Date Registered: Sept 1948
Regd No.:
(Tochigi-Otawara) 013525
Legal Status: Limited Company
(Kabushiki Kaisha)
Authorized: 500 million shares
Issued: 134,979,000 shares
Sum: Yen 20,700 million
Major shareholders (%): Toshiba Corp*
(99.4), Toshiba Insurance Service (0.6)
No. of shareholders: 2
*..
One of largest comprehensive electrical machinery mfr, Tokyo, founded
1904, listed Tokyo, Osaka, Nagoya, London S/E’s, capital Yen 439,901 million,
sales Yen 6,100,262 million, operating profit Yen 206,649 million, recurring
profit Yen 152,405 million, net profit Yen 73,705 million, total assets
5,731,246 million, net worth Yen 1,236,522 million, employees 209,784, pres
Norio Sasaki
Consolidated
Financials are attached (See SUPPLEMENTS)
Nothing detrimental
is known as to the commercial morality of executives.
Activities: Manufactures
medical equipment: diagnostic X-ray systems, medical X-ray CT systems, magnetic
resonance imaging systems, diagnostic ultrasound systems, radiation therapy
systems, diagnostic nuclear medicine systems, medical sample testing equipment,
and information for medical equipment (--100%).
Clients: Government
agencies, public hospitals, national hospitals, universities, laboratories,
other
No. of accounts:
800
Domestic areas of
activities: Nationwide
Suppliers: [Mfrs,
wholesalers] Toshiba Medical Mfg Co, Panasonic Corp, Toshiba Electron Tubes
& Devices Co, Varian Siemens Magnetic Technology, other
Payment record: Regular
Location: Business area in
Bank References:
SMBC (H/O)
Resona Bank (
Relations:
Satisfactory
(In Million
Yen)
|
Terms Ending: |
31/03/2013 |
31/03/2012 |
31/03/2011 |
31/03/2010 |
|
|
Annual
Sales |
|
265,000 |
254,959 |
248,184 |
260,064 |
|
Recur.
Profit |
|
12,000 |
11,965 |
11,175 |
10,840 |
|
Net
Profit |
|
7,500 |
7,394 |
8,367 |
6,518 |
|
Total
Assets |
|
|
157,613 |
137,934 |
140,018 |
|
Current
Assets |
|
|
105,439 |
91,737 |
94,580 |
|
Current
Liabs |
|
|
90,213 |
73,454 |
78,426 |
|
Net
Worth |
|
|
39,475 |
39,000 |
38,775 |
|
Capital,
Paid-Up |
|
|
20,700 |
20,700 |
20,700 |
|
Div.P.Share(¥) |
|
|
30.15 |
49.00 |
60.40 |
|
<Analytical Data> |
(%) |
(%) |
(%) |
(%) |
|
|
S.Growth Rate |
3.94 |
2.73 |
-4.57 |
-3.23 |
|
|
Current Ratio |
|
.. |
116.88 |
124.89 |
120.60 |
|
N.Worth Ratio |
.. |
25.05 |
28.27 |
27.69 |
|
|
R.Profit/Sales |
|
4.53 |
4.69 |
4.50 |
4.17 |
|
N.Profit/Sales |
2.83 |
2.90 |
3.37 |
2.51 |
|
|
Return On Equity |
.. |
18.73 |
21.45 |
16.81 |
|
Notes: Forecast
(or estimated) figures for the 31/03/2013 fiscal term.
CONSOLIDATED FINANCIALS OF THE PARENT, TOSHIBA CORP
|
FINANCES: (Consolidated
in million yen) |
|
|||||
|
|
|
Terms Ending: |
31/03/2012 |
31/03/2011 |
||
|
INCOME STATEMENT |
|
|
||||
|
|
Annual Sales |
|
6,100,262 |
6,398,505 |
||
|
|
Cost of Sales |
4,633,568 |
4,897,547 |
|||
|
|
GROSS PROFIT |
1,466,694 |
1,500,958 |
|||
|
|
Selling & Adm Costs |
1,260,055 |
1,260,685 |
|||
|
|
OPERATING PROFIT |
206,639 |
240,273 |
|||
|
|
Non-Operating P/L |
-54,234 |
-44,724 |
|||
|
|
RECURRING PROFIT |
152,405 |
195,549 |
|||
|
|
NET PROFIT |
73,705 |
137,845 |
|||
|
BALANCE SHEET |
|
|
|
|||
|
|
Cash |
|
214,305 |
258,840 |
||
|
|
Receivables |
|
1,307,634 |
1,124,150 |
||
|
|
Inventory |
|
884,264 |
864,382 |
||
|
|
Securities, Marketable |
|
|
|||
|
|
Other Current Assets |
595,214 |
552,296 |
|||
|
|
TOTAL CURRENT ASSETS |
3,001,417 |
2,799,668 |
|||
|
|
Property & Equipment |
851,365 |
900,205 |
|||
|
|
Intangibles |
|
711,665 |
559,246 |
||
|
|
Investments, Other Fixed Assets |
1,166,799 |
1,120,200 |
|||
|
|
TOTAL ASSETS |
5,731,246 |
5,379,319 |
|||
|
|
Payables |
|
|
|
||
|
|
Short-Term Bank Loans |
119,515 |
152,348 |
|||
|
|
|
|
|
|
||
|
|
Other Current Liabs |
2,539,745 |
2,346,061 |
|||
|
|
TOTAL CURRENT LIABS |
2,659,260 |
2,498,409 |
|||
|
|
Debentures |
|
|
|
||
|
|
Long-Term Bank Loans |
909,620 |
769,544 |
|||
|
|
Reserve for Retirement Allw |
778,580 |
734,309 |
|||
|
|
Other Debts |
|
147,264 |
197,441 |
||
|
|
TOTAL LIABILITIES |
4,494,724 |
4,199,703 |
|||
|
|
MINORITY INTERESTS |
|
|
|||
|
|
Common
stock |
439,901 |
439,901 |
|||
|
|
Additional
paid-in capital |
401,125 |
399,552 |
|||
|
|
Retained
earnings |
595,583 |
551,523 |
|||
|
|
Evaluation
p/l on investments/securities |
(567,843) |
(521,396) |
|||
|
|
Others |
|
369,254 |
311,497 |
||
|
|
Treasury
stock, at cost |
(1,498) |
(1,461) |
|||
|
|
TOTAL S/HOLDERS` EQUITY |
1,236,522 |
1,179,616 |
|||
|
|
TOTAL EQUITIES |
5,731,246 |
5,379,319 |
|||
|
CONSOLIDATED CASH FLOWS |
|
|
||||
|
|
|
Terms ending: |
31/03/2012 |
31/03/2011 |
||
|
|
Cash
Flows from Operating Activities |
|
334,997 |
374,084 |
||
|
|
Cash
Flows from Investment Activities |
-377,227 |
-214,700 |
|||
|
|
Cash
Flows from Financing Activities |
-240 |
-154,716 |
|||
|
|
Cash,
Bank Deposits at the Term End |
|
214,305 |
258,840 |
||
|
ANALYTICAL RATIOS Terms ending: |
31/03/2012 |
31/03/2011 |
||||
|
|
|
Net
Worth (S/Holders' Equity) |
1,236,522 |
1,179,616 |
||
|
|
|
Current
Ratio (%) |
112.87 |
112.06 |
||
|
|
|
Net
Worth Ratio (%) |
21.58 |
21.93 |
||
|
|
|
Recurring
Profit Ratio (%) |
2.50 |
3.06 |
||
|
|
|
Net
Profit Ratio (%) |
1.21 |
2.15 |
||
|
|
|
Return
On Equity (%) |
5.96 |
11.69 |
||
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.53.78 |
|
|
1 |
Rs.86.77 |
|
Euro |
1 |
Rs.69.71 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit transaction.
It has above average (strong) capability for payment of interest and
principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General unfavourable
factors will not cause fatal effect. Satisfactory capability for payment of
interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.